Shares in Novocure (NSDQ:NVCR) fell today after the medical device maker missed expectations on Wall Street with its first-quarter results.
The St. Helier, N.J.-based company posted a net loss of -$20.7 million, or -23¢ per share, on sales of $52.1 million for the 3 months ended March 31, for bottom-line loss of -14.8% on sales growth of 49% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Novocure misses sales, EPS estimates in Q1 appeared first on MassDevice.
from MassDevice https://ift.tt/2HZDZwL
Cap comentari:
Publica un comentari a l'entrada